Discover the full directors' dealings record of 恩华药业, a publicly traded company based in France. Shares are quoted on FR FR, under the supervision of AMF. Market capitalisation: €24.5bn. The latest transaction was filed on 22 April 2026 (Purchase). Among the most active insiders: 孙彭生. The full history is openly available.